Cargando…
Clinicopathological Features and Status of Programmed Death Ligand-1 (PD-L1) Expression in Lung Cancer: A Single Centre Study From North India
Introduction Programmed death ligand-1 (PD-L1) is an immunological checkpoint that supports the inhibition of the anti-tumor immune system. A higher level of PD-L1 expression was also discovered on the cell surfaces of several cancer cells, including non-small cell lung carcinoma (NSCLC). Identifyin...
Autores principales: | Ganie, Firdous, Mehfooz, Nazia, Siraj, Farhana, Khan, Umar H, Mantoo, Suhail, Dhar, Amrit, Mir, Mohmad Hussain, Jan, Rafi A, Shah, Sonaullah, Qadri, Syed Mudasir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024510/ https://www.ncbi.nlm.nih.gov/pubmed/36942175 http://dx.doi.org/10.7759/cureus.35056 |
Ejemplares similares
-
Tuberculosis of Finger Presenting As Non-healing Ulcer of Digit: A Case Report
por: Dhar, Amrit, et al.
Publicado: (2022) -
Vitamin D Toxicity Presenting as Altered Mental Status in Elderly Patients
por: Khan, Umar H, et al.
Publicado: (2022) -
Prevalence and predictors of pulmonary embolism in patients with acute exacerbation of chronic obstructive pulmonary disease
por: Chaudhary, Nasir, et al.
Publicado: (2021) -
Spirometric abnormalities in patients with sleep-related breathing disorders
por: Mehfooz, Nazia, et al.
Publicado: (2021) -
Nosocomial SARS-COVID-19 Outbreak During the Third Wave of COVID-19 in an Oncology Facility at a Tertiary Care Hospital in Kashmir, India
por: Siraj, Farhana, et al.
Publicado: (2023)